Please login to the form below

Not currently logged in
Email:
Password:

interferon beta-1a

This page shows the latest interferon beta-1a news and features for those working in and with pharma, biotech and healthcare.

WHO to test three more potential COVID-19 treatments

WHO to test three more potential COVID-19 treatments

Last year, WHO announced that four drugs tested in its Solidarity trial, touted as effective treatments for severe COVID-19 infection – remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon – had little or no ... Hydroxychloroquine and

Latest news

More from news
Approximately 1 fully matching, plus 58 partially matching documents found.

Latest Intelligence

  • Tackling a formidable foe Tackling a formidable foe

    Formidable foe. “With Rebif (interferon beta-1a), Merck’s legacy MS therapy approved in Europe 20 years ago, one of the innovations is the ability to have auto-injectors and devices

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...